0001705381-22-000001.txt : 20220308 0001705381-22-000001.hdr.sgml : 20220308 20220308145634 ACCESSION NUMBER: 0001705381-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 EFFECTIVENESS DATE: 20220308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CeleCor Therapeutics, Inc. CENTRAL INDEX KEY: 0001705381 IRS NUMBER: 870723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-436346 FILM NUMBER: 22721370 BUSINESS ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-777-9750 MAIL ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0708 D LIVE 0001705381 CeleCor Therapeutics, Inc. 1155 CAMINO DEL MAR SUITE 481 DEL MAR CA CALIFORNIA 92014 858-777-9750 DELAWARE None None Corporation true Robert Hillman 1155 Camino Del Mar Suite 481 Del Mar CA CALIFORNIA 92014 Executive Officer Director President, Treasurer and Director Peter B. Finn 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer Secretary Andreas Ritzi Meisenburgstrasse 3 Zug V8 SWITZERLAND 6300 Director Jack Lief 1155 Camino Del Mar Suite 481 Del Mar CA CALIFORNIA 92014 Director Biotechnology Decline to Disclose 06b false 2022-02-23 false true false 0 7500000 2700000 4800000 Up to $7,500,000 of Series B Preferred Stock. false 4 0 0 0 true false CeleCor Therapeutics, Inc. PETER B. FINN Peter B. Finn Secretary 2022-03-08